Fund HoldingsPivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value
$161.34M
Total Bought
$24.14M
Total Sold
$756.6K
Net Transaction
+$23.38M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
VAXCYTE INC(PCVX)710,7341,305,125+594,39126,83742,43026.30%+15,592
INOZYME PHARMA INC4,494,8514,494,85104,09017,97911.14%+13,889
TREVI THERAPEUTICS INC(TRVI)01,146,110+1,146,11006,2693.89%+6,269
VIGIL NEUROSCIENCE INC560,595560,59509984,4572.76%+3,459
ZENAS BIOPHARMA INC(ZBIO)736,645779,045+42,4005,8197,5494.68%+1,729
OCULIS HOLDING AG2,300,7742,300,774043,78444,65827.68%+874
BOLT BIOTHERAPEUTICS INC094,573+94,57305460.34%+546
IO BIOTECH INC864,197864,19709421,2010.74%+259
BIOAGE LABS INC(BIOA)653,374653,37402,4572,6981.67%+242
RECURSION PHARMACEUTICALS IN(RXRX)595,518595,51803,1503,0131.87%-137
RALLYBIO CORP2,404,6442,404,64401,5638130.50%-750
BOLT BIOTHERAPEUTICS INC1,891,4670-1,891,4677570-757
ARCUTIS BIOTHERAPEUTICS INC(ARQT)2,120,5082,120,508033,16529,73018.43%-3,435
Page 1 of 1